Chronic Myeloid Leukemia

• FDA approval · 2006-06-28
  FDA Approved: DASATINIB — Original Application (Prasco Laboratories)

  FDA approved dasatinib under an original application submitted by Prasco Laboratories. The approval covers treatment of Philadelphia chromos…

• CLINICAL_TRIALS research · 2006-06-26
  Clinical Trial Update: Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation [Phase 2]

  This update covers a Phase 2 trial evaluating single-unit or double-unit cord blood transplantation for hematologic malignancies, including …

• CLINICAL_TRIALS research · 2006-06-20
  Clinical Trial Update: Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase [Phase 3]

  A Phase 3 clinical trial comparing standard-dose imatinib with high-dose induction in pretreated patients with chronic-phase chronic myeloid…